πŸ‡ΊπŸ‡Έ FDA
Patent

US 9611266

Compounds and anti-tumor NQO1 substrates

granted A61KA61K31/47A61K31/4745

Quick answer

US patent 9611266 (Compounds and anti-tumor NQO1 substrates) held by The Board of Regents of the University of Texas System expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/47, A61K31/4745, A61K45/06, A61P